Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / India

Zydus Cadila To Take Stake In Simayla

June 2008 | Company News Alert

Indian generics firm Zydus Cadila has announced that it is to acquire 70% of South Africa's Simayla Pharmaceuticals, as part of its drive to penetrate southern Africa's generics markets.

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles
Tracking And Tracing Drugs To Africa

Industry / India BMI View: Legislation that all Indian pharmaceuticals will now have to be tracked and traced will make the country's generic drugs destined for Africa slightly less competitive in pricing, but more reliable...
April 2011
Indoco And Aspen Agree On License Deal

Industry / India Indian-based drugmaker Indoco has signed a licensing deal with South Africa's Aspen Pharmacare to allow the African firm to market a selection of ophthalmic products. Indoco will manufacture the medicines...
April 2010
India-Friendly Investments Incentives Announced

Industry / India The latest initiative launched by the Nigerian government to promote the country as a candidate for foreign direct investment (FDI) includes a five-year tax holiday. The directives are believed to be...
February 2010
Zydus Cadila Completes Acquisition Of Simayla

Industry / India Indian drugmaker Zydus Cadila acquired the remaining 30% stake of South Africa's Simayla Pharmaceuticals during December 2009, following its 2008 purchase of 70% of the firm. The move bolsters...
January 2010
Aspen And Matrix Reorganise Partnerships

Companies / India South Africa's Aspen Pharmacare and India's Matrix Laboratories have divested their 50-50 active pharmaceutical ingredient (API) manufacturing joint ventures. Aspen will acquire 50% of South Africa-based...
October 2008
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2012 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS